Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Candist 4mg Tablet – PA0126/206/001
- Cimeldine 400mg Film Coated Tablet – PA0126/077/002
- Cibacen 5mg Film Coated Tablet – PA2010/029/001
- Doxatan 1mg Tablet – PA0126/202/001
- Epanutin 30mg/5ml Oral Suspension – PA0822/011/007
- Esomeprazole 40mg Powder for Solution for Injection or Infusion – PA1852/002/001
- Genotropin 12mg Powder and Solvent for Solution for Injection – PA0822/128/002
- Lanoxin 500mcg/2ml Solution for Injection – PA1691/001/001
- Memantine 10mg Tablet – PA0126/255/002
- Neotigason 25mg Capsule – PA1380/050/002
- Paramax 500mg/5mg Tablet – PA0540/154/001
- Sustiva 600mg Film Coated Tablet – EU/1/99/110/009
The following shortage has been resolved and supply has resumed to the Irish market:
- Colomycin Injection 1 Million IU Powder for Solution for Injection, Infusion or Inhalation – PA1986/046/001
- Cozaar 50mg Film Coated Tablet – PA1286/004/002
- Folonic Acid 15mg Tablet – PA0822/198/001
- Irbesartan 150mg Tablet – PA0126/205/002
- Irbesartan 300mg Tablet – PA0126/205/003
- Surmontil 25mg Film Coated Tablet – PA0540/128/005
- Temozolomide 100mg Capsule – EU/1/09/606/005-006
- Temozolomide 250mg Capsule – EU/1/09/606/011-012
- Xanax 0.25mg Tablet – PA0822/141/002
- Xanax 0.5mg Tablet – PA0822/141/003
- Zerbaxa 1g/0.5g Powder for Concentrate for Solution for Infusion – EU/1/15/1032/001
- Zestan 5mg Tablet – PA0126/112/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.